Derek Maclean PhD, MSc

Derek is a pharmaceutical scientist with over 20 years of operational and management experience in medicinal chemistry, formulation development, and product manufacturing. Prior to joining Applied Molecular Transport, Derek was Vice-President of Chemistry Research at Relypsa Inc, leading the chemical development of advanced polymer therapeutics. Previously, as Director of Product Engineering at Amgen, he led late-stage drug product activities leading to the approval and commercialization of etelcalcetide, which he co-invented and led CMC development as Executive Director of Chemistry and Manufacturing at KAI Pharmaceuticals prior to its acquisition by Amgen. Before KAI he held positions of increasing responsibility at Glaxo, Affymax, and Parke-Davis. He received a Ph.D. in Organic Chemistry from the University of Edinburgh and has more than 25 peer-reviewed publications and over 10 patent filings.